Maxim Group Downgrades Capricor Therapeutics (CAPR) to Hold

July 30, 2026 8:42 AM

Maxim Group analyst Jason McCarthy downgraded Capricor Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found